(Q48189559)

9 February 2018

title

Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study (English)

1 reference

9 February 2018

0 references

Kouhei Fujimi

1

1 reference

9 February 2018

Kazuhito Noda

2

1 reference

9 February 2018

Kensuke Sasaki

3

1 reference

9 February 2018

Yoshinobu Wakisaka

4

1 reference

9 February 2018

Yumihiro Tanizaki

5

1 reference

9 February 2018

Mitsuo Iida

6

1 reference

9 February 2018

Yutaka Kiyohara

7

1 reference

9 February 2018

Shigenobu Kanba

8

1 reference

9 February 2018

Toru Iwaki

9

1 reference

9 February 2018

publication date

23 April 2007

1 reference

9 February 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

9 February 2018

volume

23

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

423-431

1 reference

9 February 2018

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

cites work

1 reference

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

Cyclooxygenases 1 and 2

1 reference

Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex

21 January 2018

1 reference

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

21 January 2018

1 reference

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

21 January 2018

1 reference

Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex

21 January 2018

1 reference

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

21 January 2018

1 reference

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

21 January 2018

1 reference

Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia

21 January 2018

1 reference

Neuronal expression of cyclooxygenase-2, a pro-inflammatory protein, in the hippocampus of patients with schizophrenia

21 January 2018

1 reference

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

21 January 2018

1 reference

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease.

21 January 2018

1 reference

Characterization of inducible cyclooxygenase in rat brain

21 January 2018

1 reference

Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice

21 January 2018

1 reference

Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000101957

1 reference

9 February 2018

1 reference

9 February 2018